Gosselies, Belgium

Julia Cuende

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Julia Cuende: Innovator in Anti-TIGIT Antibodies

Introduction

Julia Cuende is a prominent inventor based in Gosselies, Belgium. She has made significant contributions to the field of immunotherapy, particularly through her work on anti-TIGIT antibodies. With a total of 3 patents, her innovations are paving the way for new cancer treatments.

Latest Patents

Julia's latest patents focus on anti-TIGIT antibodies and antigen binding fragments that inhibit TIGIT-mediated signaling. These patents detail methods for promoting T cell activity and treating cancer using these antibodies. The full patent texts provide comprehensive information on the combinations of these antibodies with additional therapeutic agents, as well as methods applicable to human subjects.

Career Highlights

Throughout her career, Julia has worked with notable companies such as Iteos Therapeutics SA and Iteos Belgium SA. Her expertise in the development of therapeutic agents has positioned her as a key figure in the biotechnology sector.

Collaborations

Julia has collaborated with esteemed colleagues, including Catherine Hoofd and Gregory Driessens. These partnerships have further enhanced her research and development efforts in the field of immunotherapy.

Conclusion

Julia Cuende's innovative work on anti-TIGIT antibodies represents a significant advancement in cancer treatment. Her contributions continue to influence the landscape of immunotherapy and offer hope for improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…